Uso de hierro intravenoso en pacientes renales crónicos con anemia. Mayores niveles de hemoglobina a más bajo costo / Use of intravenous iron in chronic renal patients with anemia. Higher levels of hemoglobin at a lower cost

It is presented the experience with 90 patients receiving Eritropoietin s.c. and oral iron who were in chronic haemodialysis. After basic laboratories, including iron kinetic, in all of them was stopped oral iron and started i.v. iron 60 mgs per week, but keeping the same eritropoietin doses. The results showed an increased haemoglobin level from 6.5 to 11 g/dl mean values and a decreased doses of eritropoietin between 25 to 50%. This represent an important elevation of haemoglobin levels at a significant low cost

Uso de eritropoyetina en pacientes con insuficiencia renal crónica y en hemodiálisis / Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis

Erythropoietin (EP) injected subcutaneously (SC) 2 or 3 times a week, respectively, or intravenously (IV) 3 times a week, increased the hemoglobin and the hematocrit of all the patients so treated. The total units of EP used was less when it was administered SC. EP once or twice a week, respectively, administered SC also increased the hemoglobin and hematocrit in each case, and the total amount of EP used was also less